News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eppendorf AG Announces It Has Received Connecticut State Approval to Conduct Biosafety Level 2 Infectious Disease Related Research


10/21/2013 9:38:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ENFIELD, Conn.--(BUSINESS WIRE)--Eppendorf is proud to announce they have received Connecticut State approval to conduct Biosafety Level 2 (BL2) infectious disease related research. This greatly expands the capabilities of the Eppendorf Research and Development Laboratory located at their Enfield facility, and enhances research plans and activities for customers. “We plan to further our research in stem cell bioprocess to include induced pluripotent stem cells (IPSCs)” stated Dr. Ma Sha, Director, Technical Applications. “We are also actively seeking industry or industry/academia collaborations in the stem cell bioprocess area.”

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES